Order Article Reprints

Lv M, Liang Q, Luo Z, Han B, Ni T, Wang Y, Tao L, Lyu W, Xiang J, Liu Y. UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study. Metabolites. 2022; 12(9):839. https://doi.org/10.3390/metabo12090839

Lv, Mengying, Qiaoling Liang, Zhaoyong Luo, Bo Han, Tengyang Ni, Yang Wang, Li Tao, Weiting Lyu, Jie Xiang, and Yanqing Liu. 2022. "UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study" Metabolites 12, no. 9: 839. https://doi.org/10.3390/metabo12090839

Lv, M., Liang, Q., Luo, Z., Han, B., Ni, T., Wang, Y., Tao, L., Lyu, W., Xiang, J., & Liu, Y. (2022). UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study. Metabolites, 12(9), 839. https://doi.org/10.3390/metabo12090839